▶ 調査レポート

経皮パッチの世界市場レポート2020

• 英文タイトル:Global Transdermal Patch Sales Market Report 2020

が調査・発行した産業分析レポートです。経皮パッチの世界市場レポート2020 / Global Transdermal Patch Sales Market Report 2020 / MRC2102QY15235資料のイメージです。• レポートコード:MRC2102QY15235
• 出版社/出版日: / 2021年1月
• レポート形態:英文、PDF、147ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品、医療
• 販売価格(消費税別)
  Single User¥592,000 (USD4,000)▷ お問い合わせ
  Multi User¥888,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,184,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYリサーチ社の本調査レポートでは、世界の経皮パッチ市場について種類別(サリチル酸メチル系パッチ、リバスチグミン系パッチ、フェンタニル系パッチ、リドカイン系パッチ、ジクロフェナク系パッチ、ニコチン系パッチ、その他)、用途別(Rxチャンネル、OTCチャンネル)、地域別(米国、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・経皮パッチ市場の概要
・世界の主要地域別経皮パッチ市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の経皮パッチ市場規模2015-2026:種類別(サリチル酸メチル系パッチ、リバスチグミン系パッチ、フェンタニル系パッチ、リドカイン系パッチ、ジクロフェナク系パッチ、ニコチン系パッチ、その他)
・世界の経皮パッチ市場規模2015-2026:用途別(Rxチャンネル、OTCチャンネル)
・経皮パッチの米国市場規模2015-2020
・経皮パッチのヨーロッパ市場規模2015-2020
・経皮パッチの中国市場規模2015-2020
・経皮パッチの日本市場規模2015-2020
・経皮パッチの東南アジア市場規模2015-2020
・経皮パッチのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・経皮パッチの製造コスト分析
・販売チャネル、流通業者、顧客
・経皮パッチの市場動向・機会・課題
・調査の結論

Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
Transdermal Patches are mainly classified into the following types: Methyl Salicylate-based Patches, Rivastigmine Patches, Fentanyl Patches, Lidocaine Patches, Diclofenac Patches, Nicotine Patches and others. Methyl Salicylate-based segment accounted for the larger part of the revenue market, with 18.25% in 2019, followed by Lidocaine Patches, with 15.22%.
Transdermal Patches can delivery drugs through Rx Channel or OTC Channel. The former took a larger market share in 2019, with its sales volume accounting for about 76.25% of the total.
Hisamitsu Pharmaceutical, Johnson & Johnson, Nitto Denko and Mylan are the Top 4 players of the global Transdermal Patch market. They took up about 41.69% of the global market in 2019.

Market Analysis and Insights: Global Transdermal Patch Market
The global Transdermal Patch market size is projected to reach US$ 7924.6 million by 2026, from US$ 6428 million in 2020, at a CAGR of 3.6% during 2021-2026.

Global Transdermal Patch Scope and Market Size
The global Transdermal Patch market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Transdermal Patch market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Transdermal Patch market is segmented into
Methyl Salicylate-Based Patch
Rivastigmine Patch
Fentanyl Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Patch
Others

Segment by Application, the Transdermal Patch market is segmented into
Rx Channel
OTC Channel

The Transdermal Patch market is analysed and market size information is provided by regions (countries). Segment by Application, the Transdermal Patch market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Transdermal Patch Market Share Analysis
Transdermal Patch market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Transdermal Patch business, the date to enter into the Transdermal Patch market, Transdermal Patch product introduction, recent developments, etc.

The major vendors covered:
Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan
Teva Pharmaceutical
Nitto Denko
Grünenthal
IBSA Group
GSK
Luye Pharma Group
Pfizer
Chattem
Dr Reddy’s Laboratories
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical

レポート目次

1 Transdermal Patch Market Overview
1.1 Transdermal Patch Product Scope
1.2 Transdermal Patch Segment by Type
1.2.1 Global Transdermal Patch Sales by Type (2020-2026)
1.2.2 Methyl Salicylate-Based Patch
1.2.3 Rivastigmine Patch
1.2.4 Fentanyl Patch
1.2.5 Lidocaine Patch
1.2.6 Diclofenac Patch
1.2.7 Nicotine Patch
1.2.8 Others
1.3 Transdermal Patch Segment by Application
1.3.1 Global Transdermal Patch Sales Comparison by Application (2020-2026)
1.3.2 Rx Channel
1.3.3 OTC Channel
1.4 Transdermal Patch Market Estimates and Forecasts (2015-2026)
1.4.1 Global Transdermal Patch Sales Growth Rate (2015-2026)
1.4.2 Global Transdermal Patch Revenue and Growth Rate (2015-2026)
1.4.3 Global Transdermal Patch Price Trends (2015-2026)

2 Transdermal Patch Estimate and Forecast by Region
2.1 Global Transdermal Patch Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Transdermal Patch Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Transdermal Patch Sales Market Share by Region (2015-2020)
2.2.2 Global Transdermal Patch Revenue Market Share by Region (2015-2020)
2.3 Global Transdermal Patch Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Transdermal Patch Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Transdermal Patch Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Transdermal Patch Estimates and Projections (2015-2026)
2.4.2 Europe Transdermal Patch Estimates and Projections (2015-2026)
2.4.3 China Transdermal Patch Estimates and Projections (2015-2026)
2.4.4 Japan Transdermal Patch Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Transdermal Patch Estimates and Projections (2015-2026)
2.4.6 India Transdermal Patch Estimates and Projections (2015-2026)
3 Global Transdermal Patch Competition Landscape by Players
3.1 Global Top Transdermal Patch Players by Sales (2015-2020)
3.2 Global Top Transdermal Patch Players by Revenue (2015-2020)
3.3 Global Transdermal Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Patch as of 2019)
3.4 Global Transdermal Patch Average Price by Company (2015-2020)
3.5 Manufacturers Transdermal Patch Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Transdermal Patch Players (Opinion Leaders)
4 Global Transdermal Patch Market Size by Type
4.1 Global Transdermal Patch Historic Market Review by Type (2015-2020)
4.1.1 Global Transdermal Patch Sales Market Share by Type (2015-2020)
4.1.2 Global Transdermal Patch Revenue Market Share by Type (2015-2020)
4.1.3 Global Transdermal Patch Price by Type (2015-2020)
4.2 Global Transdermal Patch Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Transdermal Patch Sales Forecast by Type (2021-2026)
4.2.2 Global Transdermal Patch Revenue Forecast by Type (2021-2026)
4.2.3 Global Transdermal Patch Price Forecast by Type (2021-2026)
5 Global Transdermal Patch Market Size by Application
5.1 Global Transdermal Patch Historic Market Review by Application (2015-2020)
5.1.1 Global Transdermal Patch Sales Market Share by Application (2015-2020)
5.1.2 Global Transdermal Patch Revenue Market Share by Application (2015-2020)
5.1.3 Global Transdermal Patch Price by Application (2015-2020)
5.2 Global Transdermal Patch Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Transdermal Patch Sales Forecast by Application (2021-2026)
5.2.2 Global Transdermal Patch Revenue Forecast by Application (2021-2026)
5.2.3 Global Transdermal Patch Price Forecast by Application (2021-2026)

6 United States Transdermal Patch Market Facts & Figures
6.1 United States Transdermal Patch Sales Market Share by Company (2015-2020)
6.2 United States Transdermal Patch Sales Market Share by Type (2015-2020)
6.3 United States Transdermal Patch Sales Market Share by Application (2015-2020)

7 Europe Transdermal Patch Market Facts & Figures
7.1 Europe Transdermal Patch Sales Market Share by Company (2015-2020)
7.2 Europe Transdermal Patch Sales Market Share by Type (2015-2020)
7.3 Europe Transdermal Patch Sales Market Share by Application (2015-2020)

8 China Transdermal Patch Market Facts & Figures
8.1 China Transdermal Patch Sales Market Share by Company (2015-2020)
8.2 China Transdermal Patch Sales Market Share by Type (2015-2020)
8.3 China Transdermal Patch Sales Market Share by Application (2015-2020)

9 Japan Transdermal Patch Market Facts & Figures
9.1 Japan Transdermal Patch Sales Market Share by Company (3015-3030)
9.2 Japan Transdermal Patch Sales Market Share by Type (2015-2020)
9.3 Japan Transdermal Patch Sales Market Share by Application (2015-2020)

10 Southeast Asia Transdermal Patch Market Facts & Figures
10.1 Southeast Asia Transdermal Patch Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Transdermal Patch Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Transdermal Patch Sales Market Share by Application (2015-2020)

11 India Transdermal Patch Market Facts & Figures
11.1 India Transdermal Patch Sales Market Share by Company (2015-2020)
11.2 India Transdermal Patch Sales Market Share by Type (2015-2020)
11.3 India Transdermal Patch Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Transdermal Patch Business
12.1 Hisamitsu Pharmaceutical
12.1.1 Hisamitsu Pharmaceutical Corporation Information
12.1.2 Hisamitsu Pharmaceutical Business Overview
12.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Hisamitsu Pharmaceutical Transdermal Patch Products Offered
12.1.5 Hisamitsu Pharmaceutical Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Corporation Information
12.2.2 Johnson & Johnson Business Overview
12.2.3 Johnson & Johnson Transdermal Patch Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Johnson & Johnson Transdermal Patch Products Offered
12.2.5 Johnson & Johnson Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Business Overview
12.3.3 Novartis Transdermal Patch Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Novartis Transdermal Patch Products Offered
12.3.5 Novartis Recent Development
12.4 UCB Pharma
12.4.1 UCB Pharma Corporation Information
12.4.2 UCB Pharma Business Overview
12.4.3 UCB Pharma Transdermal Patch Sales, Revenue and Gross Margin (2015-2020)
12.4.4 UCB Pharma Transdermal Patch Products Offered
12.4.5 UCB Pharma Recent Development
12.5 Mylan
12.5.1 Mylan Corporation Information
12.5.2 Mylan Business Overview
12.5.3 Mylan Transdermal Patch Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Mylan Transdermal Patch Products Offered
12.5.5 Mylan Recent Development
12.6 Teva Pharmaceutical
12.6.1 Teva Pharmaceutical Corporation Information
12.6.2 Teva Pharmaceutical Business Overview
12.6.3 Teva Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Teva Pharmaceutical Transdermal Patch Products Offered
12.6.5 Teva Pharmaceutical Recent Development
12.7 Nitto Denko
12.7.1 Nitto Denko Corporation Information
12.7.2 Nitto Denko Business Overview
12.7.3 Nitto Denko Transdermal Patch Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Nitto Denko Transdermal Patch Products Offered
12.7.5 Nitto Denko Recent Development
12.8 Grünenthal
12.8.1 Grünenthal Corporation Information
12.8.2 Grünenthal Business Overview
12.8.3 Grünenthal Transdermal Patch Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Grünenthal Transdermal Patch Products Offered
12.8.5 Grünenthal Recent Development
12.9 IBSA Group
12.9.1 IBSA Group Corporation Information
12.9.2 IBSA Group Business Overview
12.9.3 IBSA Group Transdermal Patch Sales, Revenue and Gross Margin (2015-2020)
12.9.4 IBSA Group Transdermal Patch Products Offered
12.9.5 IBSA Group Recent Development
12.10 GSK
12.10.1 GSK Corporation Information
12.10.2 GSK Business Overview
12.10.3 GSK Transdermal Patch Sales, Revenue and Gross Margin (2015-2020)
12.10.4 GSK Transdermal Patch Products Offered
12.10.5 GSK Recent Development
12.11 Luye Pharma Group
12.11.1 Luye Pharma Group Corporation Information
12.11.2 Luye Pharma Group Business Overview
12.11.3 Luye Pharma Group Transdermal Patch Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Luye Pharma Group Transdermal Patch Products Offered
12.11.5 Luye Pharma Group Recent Development
12.12 Pfizer
12.12.1 Pfizer Corporation Information
12.12.2 Pfizer Business Overview
12.12.3 Pfizer Transdermal Patch Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Pfizer Transdermal Patch Products Offered
12.12.5 Pfizer Recent Development
12.13 Chattem
12.13.1 Chattem Corporation Information
12.13.2 Chattem Business Overview
12.13.3 Chattem Transdermal Patch Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Chattem Transdermal Patch Products Offered
12.13.5 Chattem Recent Development
12.14 Dr Reddy’s Laboratories
12.14.1 Dr Reddy’s Laboratories Corporation Information
12.14.2 Dr Reddy’s Laboratories Business Overview
12.14.3 Dr Reddy’s Laboratories Transdermal Patch Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Dr Reddy’s Laboratories Transdermal Patch Products Offered
12.14.5 Dr Reddy’s Laboratories Recent Development
12.15 Bayer
12.15.1 Bayer Corporation Information
12.15.2 Bayer Business Overview
12.15.3 Bayer Transdermal Patch Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Bayer Transdermal Patch Products Offered
12.15.5 Bayer Recent Development
12.16 Mundipharma
12.16.1 Mundipharma Corporation Information
12.16.2 Mundipharma Business Overview
12.16.3 Mundipharma Transdermal Patch Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Mundipharma Transdermal Patch Products Offered
12.16.5 Mundipharma Recent Development
12.17 Endo International
12.17.1 Endo International Corporation Information
12.17.2 Endo International Business Overview
12.17.3 Endo International Transdermal Patch Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Endo International Transdermal Patch Products Offered
12.17.5 Endo International Recent Development
12.18 Beijing Tide Pharmaceutical
12.18.1 Beijing Tide Pharmaceutical Corporation Information
12.18.2 Beijing Tide Pharmaceutical Business Overview
12.18.3 Beijing Tide Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Beijing Tide Pharmaceutical Transdermal Patch Products Offered
12.18.5 Beijing Tide Pharmaceutical Recent Development

13 Transdermal Patch Manufacturing Cost Analysis
13.1 Transdermal Patch Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Transdermal Patch
13.4 Transdermal Patch Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Transdermal Patch Distributors List
14.3 Transdermal Patch Customers

15 Market Dynamics
15.1 Transdermal Patch Market Trends
15.2 Transdermal Patch Opportunities and Drivers
15.3 Transdermal Patch Market Challenges
15.4 Transdermal Patch Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Transdermal Patch Sales (M Pcs) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Transdermal Patch Sales (M Pcs) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Transdermal Patch Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Transdermal Patch Sales (M Pcs) by Region (2015-2020)
Table 5. Global Transdermal Patch Sales Market Share by Region (2015-2020)
Table 6. Global Transdermal Patch Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Transdermal Patch Revenue Share by Region (2015-2020)
Table 8. Global Transdermal Patch Sales (M Pcs) Forecast by Region (2021-2026)
Table 9. Global Transdermal Patch Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Transdermal Patch Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Transdermal Patch Revenue Share Forecast by Region (2021-2026)
Table 12. Global Transdermal Patch (M Pcs) of Key Companies (2015-2020)
Table 13. Global Transdermal Patch Sales Share by Company (2015-2020)
Table 14. Global Transdermal Patch Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Transdermal Patch Revenue Share by Company (2015-2020)
Table 16. Global Transdermal Patch by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Patch as of 2019)
Table 17. Global Transdermal Patch Average Price (USD/Pc) of Key Company (2015-2020)
Table 18. Manufacturers Transdermal Patch Manufacturing Sites and Area Served
Table 19. Manufacturers Transdermal Patch Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Transdermal Patch Players
Table 22. Global Transdermal Patch Sales (M Pcs) by Type (2015-2020)
Table 23. Global Transdermal Patch Sales Share by Type (2015-2020)
Table 24. Global Transdermal Patch Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Transdermal Patch Price (M Pcs) by Type (2015-2020)
Table 26. Global Transdermal Patch Sales Share by Type (2021-2026)
Table 27. Global Transdermal Patch Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Transdermal Patch Revenue Share by Type (2021-2026)
Table 29. Global Transdermal Patch Price (M Pcs) by Type (2021-2026)
Table 30. Global Transdermal Patch Sales (M Pcs) by Application (2015-2020)
Table 31. Global Transdermal Patch Sales Share by Application (2015-2020)
Table 32. Global Transdermal Patch Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Transdermal Patch Price (M Pcs) by Application (2015-2020)
Table 34. Global Transdermal Patch Sales (M Pcs) by Application (2021-2026)
Table 35. Global Transdermal Patch Sales Share by Application (2021-2026)
Table 36. Global Transdermal Patch Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Transdermal Patch Revenue Share by Application (2021-2026)
Table 38. Global Transdermal Patch Price (M Pcs) by Application (2021-2026)
Table 39. United States Transdermal Patch Sales (M Pcs) by Company (2015-2020)
Table 40. United States Transdermal Patch Sales Market Share by Company (2015-2020)
Table 41. United States Transdermal Patch Sales (M Pcs) by Type (2015-2020)
Table 42. United States Transdermal Patch Sales Market Share by Type (2015-2020)
Table 43. United States Transdermal Patch Sales (M Pcs) by Application (2015-2020)
Table 44. United States Transdermal Patch Sales Market Share by Application (2015-2020)
Table 45. Europe Transdermal Patch Sales (M Pcs) by Company (2015-2020)
Table 46. Europe Transdermal Patch Sales Market Share by Company (2015-2020)
Table 47. Europe Transdermal Patch Sales (M Pcs) by Type (2015-2020)
Table 48. Europe Transdermal Patch Sales Market Share by Type (2015-2020)
Table 49. Europe Transdermal Patch Sales (M Pcs) by Application (2015-2020)
Table 50. Europe Transdermal Patch Sales Market Share by Type (2015-2020)
Table 51. China Transdermal Patch Sales (M Pcs) by Company (2015-2020)
Table 52. China Transdermal Patch Sales Market Share by Company (2015-2020)
Table 53. China Transdermal Patch Sales (M Pcs) by Type (2015-2020)
Table 54. China Transdermal Patch Sales Market Share by Type (2015-2020)
Table 55. China Transdermal Patch Sales (M Pcs) by Application (2015-2020)
Table 56. China Transdermal Patch Sales Market Share by Application (2015-2020)
Table 57. Japan Transdermal Patch Sales (M Pcs) by Company (2015-2020)
Table 58. Japan Transdermal Patch Sales Market Share by Company (2015-2020)
Table 59. Japan Transdermal Patch Sales (M Pcs) by Type (2015-2020)
Table 60. Japan Transdermal Patch Sales Market Share by Type (2015-2020)
Table 61. Japan Transdermal Patch Sales (M Pcs) by Application (2015-2020)
Table 62. Japan Transdermal Patch Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Transdermal Patch Sales (M Pcs) by Company (2015-2020)
Table 64. Southeast Asia Transdermal Patch Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Transdermal Patch Sales (M Pcs) by Type (2015-2020)
Table 66. Southeast Asia Transdermal Patch Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Transdermal Patch Sales (M Pcs) by Type (2015-2020)
Table 68. Southeast Asia Transdermal Patch Sales Market Share by Application (2015-2020)
Table 69. India Transdermal Patch Sales (M Pcs) by Company (2015-2020)
Table 70. India Transdermal Patch Sales Market Share by Company (2015-2020)
Table 71. India Transdermal Patch Sales (M Pcs) by Type (2015-2020)
Table 72. India Transdermal Patch Sales Market Share by Type (2015-2020)
Table 73. India Transdermal Patch Sales (M Pcs) by Application (2015-2020)
Table 74. India Transdermal Patch Sales Market Share by Application (2015-2020)
Table 75. Hisamitsu Pharmaceutical Corporation Information
Table 76. Hisamitsu Pharmaceutical Description and Business Overview
Table 77. Hisamitsu Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2015-2020)
Table 78. Hisamitsu Pharmaceutical Transdermal Patch Product
Table 79. Hisamitsu Pharmaceutical Recent Development
Table 80. Johnson & Johnson Corporation Information
Table 81. Johnson & Johnson Description and Business Overview
Table 82. Johnson & Johnson Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2015-2020)
Table 83. Johnson & Johnson Transdermal Patch Product
Table 84. Johnson & Johnson Recent Development
Table 85. Novartis Corporation Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2015-2020)
Table 88. Novartis Transdermal Patch Product
Table 89. Novartis Recent Development
Table 90. UCB Pharma Corporation Information
Table 91. UCB Pharma Description and Business Overview
Table 92. UCB Pharma Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2015-2020)
Table 93. UCB Pharma Transdermal Patch Product
Table 94. UCB Pharma Recent Development
Table 95. Mylan Corporation Information
Table 96. Mylan Description and Business Overview
Table 97. Mylan Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2015-2020)
Table 98. Mylan Transdermal Patch Product
Table 99. Mylan Recent Development
Table 100. Teva Pharmaceutical Corporation Information
Table 101. Teva Pharmaceutical Description and Business Overview
Table 102. Teva Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2015-2020)
Table 103. Teva Pharmaceutical Transdermal Patch Product
Table 104. Teva Pharmaceutical Recent Development
Table 105. Nitto Denko Corporation Information
Table 106. Nitto Denko Description and Business Overview
Table 107. Nitto Denko Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2015-2020)
Table 108. Nitto Denko Transdermal Patch Product
Table 109. Nitto Denko Recent Development
Table 110. Grünenthal Corporation Information
Table 111. Grünenthal Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2015-2020)
Table 112. Grünenthal Description and Business Overview
Table 113. Grünenthal Transdermal Patch Product
Table 114. Grünenthal Recent Development
Table 115. IBSA Group Corporation Information
Table 116. IBSA Group Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2015-2020)
Table 117. IBSA Group Description and Business Overview
Table 118. IBSA Group Transdermal Patch Product
Table 119. IBSA Group Recent Development
Table 120. GSK Corporation Information
Table 121. GSK Description and Business Overview
Table 122. GSK Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2015-2020)
Table 123. GSK Transdermal Patch Product
Table 124. GSK Recent Development
Table 125. Luye Pharma Group Corporation Information
Table 126. Luye Pharma Group Description and Business Overview
Table 127. Luye Pharma Group Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2015-2020)
Table 128. Luye Pharma Group Transdermal Patch Product
Table 129. Luye Pharma Group Recent Development
Table 130. Pfizer Corporation Information
Table 131. Pfizer Description and Business Overview
Table 132. Pfizer Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2015-2020)
Table 133. Pfizer Transdermal Patch Product
Table 134. Pfizer Recent Development
Table 135. Chattem Corporation Information
Table 136. Chattem Description and Business Overview
Table 137. Chattem Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2015-2020)
Table 138. Chattem Transdermal Patch Product
Table 139. Chattem Recent Development
Table 140. Dr Reddy’s Laboratories Corporation Information
Table 141. Dr Reddy’s Laboratories Description and Business Overview
Table 142. Dr Reddy’s Laboratories Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2015-2020)
Table 143. Dr Reddy’s Laboratories Transdermal Patch Product
Table 144. Dr Reddy’s Laboratories Recent Development
Table 145. Bayer Corporation Information
Table 146. Bayer Description and Business Overview
Table 147. Bayer Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2015-2020)
Table 148. Bayer Transdermal Patch Product
Table 149. Bayer Recent Development
Table 150. Mundipharma Corporation Information
Table 151. Mundipharma Description and Business Overview
Table 152. Mundipharma Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2015-2020)
Table 153. Mundipharma Transdermal Patch Product
Table 154. Mundipharma Recent Development
Table 155. Endo International Corporation Information
Table 156. Endo International Description and Business Overview
Table 157. Endo International Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2015-2020)
Table 158. Endo International Transdermal Patch Product
Table 159. Endo International Recent Development
Table 160. Beijing Tide Pharmaceutical Corporation Information
Table 161. Beijing Tide Pharmaceutical Description and Business Overview
Table 162. Beijing Tide Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (Million USD), Price (USD/Pc) and Gross Margin (2015-2020)
Table 163. Beijing Tide Pharmaceutical Transdermal Patch Product
Table 164. Beijing Tide Pharmaceutical Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Transdermal Patch Distributors List
Table 168. Transdermal Patch Customers List
Table 169. Transdermal Patch Market Key Trends
Table 170. Transdermal Patch Key Opportunities and Drivers
Table 171. Transdermal Patch Market Challenges
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Transdermal Patch Product Picture
Figure 2. Global Transdermal Patch Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Transdermal Patch Market Share by Application in 2020 & 2026
Figure 6. Rx Channel Examples
Figure 7. OTC Channel Examples
Figure 8. Global Transdermal Patch Sales (M Pcs) Growth Rate (2015-2026)
Figure 9. Global Transdermal Patch Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Transdermal Patch Price Trends Growth Rate (2015-2026) (USD/Pc)
Figure 11. Global Transdermal Patch Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Transdermal Patch Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Transdermal Patch Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Transdermal Patch Sales (M Pcs) Growth Rate (2015-2026)
Figure 15. Europe Transdermal Patch Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Transdermal Patch Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Transdermal Patch Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Transdermal Patch Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Transdermal Patch Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Transdermal Patch Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Transdermal Patch Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Transdermal Patch Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Transdermal Patch Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Transdermal Patch Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Transdermal Patch Players Market Share by Revenue in Transdermal Patch 2015 & 2019
Figure 26. Transdermal Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Transdermal Patch Revenue Share by Type (2015-2020)
Figure 28. Global Transdermal Patch Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Transdermal Patch Revenue Share by Application (2015-2020)
Figure 30. Global Transdermal Patch Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Transdermal Patch Sales Market Share by Type in 2019
Figure 32. United States Transdermal Patch Sales Market Share by Type in 2019
Figure 33. Europe Transdermal Patch Sales Market Share by Company in 2019
Figure 34. Europe Transdermal Patch Sales Market Share by Type in 2019
Figure 35. Europe Transdermal Patch Sales Market Share by Application in 2019
Figure 36. China Transdermal Patch Sales Market Share by Company in 2019
Figure 37. China Transdermal Patch Sales Market Share by Type in 2019
Figure 38. China Transdermal Patch Sales Market Share by Application in 2019
Figure 39. Japan Transdermal Patch Sales Market Share by Company in 2019
Figure 40. Japan Transdermal Patch Sales Market Share by Type in 2019
Figure 41. Japan Transdermal Patch Sales Market Share by Application in 2019
Figure 42. Southeast Asia Transdermal Patch Sales Market Share by Company in 2019
Figure 43. Southeast Asia Transdermal Patch Sales Market Share by Type in 2019
Figure 44. Southeast Asia Transdermal Patch Sales Market Share by Application in 2019
Figure 45. India Transdermal Patch Sales Market Share by Company in 2019
Figure 46. India Transdermal Patch Sales Market Share by Type in 2019
Figure 47. India Transdermal Patch Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Transdermal Patch
Figure 50. Manufacturing Process Analysis of Transdermal Patch
Figure 51. Transdermal Patch Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed